Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,486.00p

Buy

1,487.00p

arrow-down-2.00p (-0.13%)

Prices updated at 12 Jun 2026, 18:38 BST

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company ...

FTSE All-Share

1.61%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	1,500.00p - 1,465.00p
	2,142.73p - 1,187.00p
	4.18
	3,137.82m
	10.97
	500
	323,251
	1.62
	856,900.30
	0.42
	234.72m
	GB00B0LCW083
	1.81
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.